.svg){kind=small}
Discover opportunities months before the RFP drops
Learn more →Discover opportunities months before the RFP drops
Learn more →Key metrics and characteristics
The city where this buyer is located.
The county where this buyer is located.
Physical address of this buyer.
Postal code for this buyer's location.
How likely this buyer is to spend on new technology based on operating budget trends.
How likely this buyer is to adopt new AI technologies.
How often this buyer champions startups and early adoption.
Includes fiscal year calendars, procurement complexity scores, and strategic insights.
Synthesizing live web signals with exclusive contracts, FOIA docs, and board-level intelligence.
Ask a question to get started or click a suggestion below.
Search across Melanoma Research Alliance's meeting minutes, FOIA documents, procurement records, and public filings. Our AI reads thousands of sources so you don't have to.
Keep your public sector contacts fresh and actionable. No more stale data.
Premium
Win more deals with deep buyer insights
Premium
Access the largest public sector contact database
Active opportunities open for bidding
Melanoma Research Alliance
The RFP aims to support clinical validation studies or phase I clinical trials using new or improved imaging technologies, biomarkers, monitoring algorithms, diagnostic or screening tests, or devices. Studies proposing the use of technologies that are easily scalable are encouraged.
Posted Date
Sep 17, 2025
Due Date
Feb 3, 2026
Release: Sep 17, 2025
Melanoma Research Alliance
Close: Feb 3, 2026
The RFP aims to support clinical validation studies or phase I clinical trials using new or improved imaging technologies, biomarkers, monitoring algorithms, diagnostic or screening tests, or devices. Studies proposing the use of technologies that are easily scalable are encouraged.
AvailableMelanoma Research Alliance
Pre-clinical, translational, and early clinical research with the potential to produce unusually high impact, near-term advancements in melanoma prevention, detection, diagnosis, and treatment. Owner is soliciting proposals that address the gap in translational science (i.e., turning scientific discoveries into tools and/or treatments for high-risk individuals and patients with melanoma). Successful proposals have the potential of applying important basic and preclinical discoveries to the near-term development of clinical trials and studies impacting melanoma detection, prevention, diagnosis, and/or treatment. Proposals for clinical studies testing well-defined and clearly articulated hypotheses are welcome and should be accompanied by a brief protocol synopsis and timeline with milestones. IRB approval is not required at the time of application but is required before initial payments are made to an awarded proposal.
Posted Date
Aug 15, 2025
Due Date
Nov 7, 2025
Release: Aug 15, 2025
Melanoma Research Alliance
Close: Nov 7, 2025
Pre-clinical, translational, and early clinical research with the potential to produce unusually high impact, near-term advancements in melanoma prevention, detection, diagnosis, and treatment. Owner is soliciting proposals that address the gap in translational science (i.e., turning scientific discoveries into tools and/or treatments for high-risk individuals and patients with melanoma). Successful proposals have the potential of applying important basic and preclinical discoveries to the near-term development of clinical trials and studies impacting melanoma detection, prevention, diagnosis, and/or treatment. Proposals for clinical studies testing well-defined and clearly articulated hypotheses are welcome and should be accompanied by a brief protocol synopsis and timeline with milestones. IRB approval is not required at the time of application but is required before initial payments are made to an awarded proposal.
Melanoma Research Alliance
Provide preclinical, translational, and early clinical research with the potential to produce unusually high impact and near-term advancements in melanoma prevention, detection, diagnosis, and treatment.
Posted Date
Aug 12, 2024
Due Date
Sep 28, 2024
Release: Aug 12, 2024
Melanoma Research Alliance
Close: Sep 28, 2024
Provide preclinical, translational, and early clinical research with the potential to produce unusually high impact and near-term advancements in melanoma prevention, detection, diagnosis, and treatment.
Get alerted before the bid drops, know which RFPs to pursue, and generate compliant drafts with AI.
.avif&w=256&q=75){kind=small}
.avif&w=256&q=75){kind=small}
.avif&w=256&q=75){kind=small}
.avif&w=256&q=75){kind=small}
.avif&w=256&q=75){kind=small}
.avif&w=256&q=75){kind=small}
.avif&w=256&q=75){kind=small}